Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

iSpecimen Inc

Overview

This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.

iSpecimen has built a partner network comprised of supplying institutions that have ethically acquired human biospecimens and created biorepositories/biobanks to store the specimens and data. Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples. This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.

Study Type

OBSERVATIONAL

Conditions

Cancer Pregnancy Related Gastro-Intestinal Disorder Cardio-Respiratory Distress Women's Health: Endometriosis Autoimmune Diseases Nephritis Healthy Neuro-Degenerative Disease

Interventions

Specimens obtained from surgical, phlebotomy or other non-invasive procedurePROCEDURE

Biospecimen Collection

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Specimens and/or data from Biorepositories that have enrolled subjects that have provided consent for the specimens and de-identified data to be collected, stored and distributed. * Specimens from biobanks that have collected materials and de-identified data under a waiver of consent * Specimens from a biobank that meet the criteria for non human subject research under the common rule. Exclusion Criteria: * Specimens and/or that have been obtained from subjects without informed consent, nor waiver of consent or that do not meet the criteria for non human subject research under the common rule.

Locations (1)

iSpecimen

Lexington, Massachusetts, United States

Outcomes

Primary Outcomes

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

The number of specimens and subjects distributed per disease will be measured and reported.

Time frame: 15 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.